Custom service
Peptide Crystallization
Crystallize peptides for structural determination
Peptide Crystallization supports programmes that crystallize peptides for structural determination. In a typical engagement we plan the sparse-matrix crystallization screens route first, confirm compatibility with co-crystallization with ligands, and release crystals or solved structure per agreement on a 6–12 weeks schedule.
Chemistry is chosen for the molecule, not from a menu. Where the payload tolerates it we keep sparse-matrix crystallization screens as the primary option and hold co-crystallization with ligands in reserve, so that scale-up never depends on an unproven step.
Structural confirmation of novel folds
Rationalizing SAR with atomic detail
Flexible peptides with no crystallization chance
Samples requiring containment or licensing we do not hold (BSL-3, radioactive)
Analytical reports follow a fixed template: sample condition on receipt, method description with validation status, raw chromatograms and spectra, results with uncertainty, and an interpretation note. Urgent same-week slots are available for release-critical testing.
Service Highlights
- Sparse-matrix crystallization screens as the default route, with co-crystallization with ligands held as a proven fallback
- X-ray data collection support worked into the design where the application requires it
- Results are reported with detection limits and method validation status, so you know exactly what the number means
- Analytical confirmation of every intermediate before the final release
- Orthogonal methods are used by default — one measurement is an observation, two are data
- Crystals or solved structure per agreement delivered with a complete conjugation or synthesis certificate
How the work runs
Sample intake & plan
Samples are logged with chain of custody and the test matrix for Peptide Crystallization is confirmed.
Method selection
Analytical methods — sparse-matrix crystallization screens, co-crystallization with ligands — are chosen and their validation status documented.
Measurement
Testing is executed with system-suitability checks and orthogonal confirmation where required.
Data review
Chromatograms and spectra are reviewed by a second analyst before any result is issued.
Reporting
Crystals or solved structure per agreement is issued with detection limits and interpretation notes.
Follow-up support
We discuss anomalies and, where useful, propose the follow-up experiment that resolves them.
Specifications & timeline
- Turnaround
- 6–12 weeks
- Typical scale
- µg – g sample scale
- Chemistry options
- sparse-matrix crystallization screens; co-crystallization with ligands; X-ray data collection support
- Deliverable
- Crystals or solved structure per agreement
- QC package
- Method report, raw data, validated result with detection limits
- Shipping
- Blue ice or ambient by material; chain-of-custody on receipt
Related Products
- Recombinant ProteinsGrowth factors, cytokines and antigens produced across E. coli, yeast, insect and mammalian hosts — over 10,000 items on the shelf and ready to move.
- Native ProteinsIsolated directly from natural sources, preserving native post-translational modifications and conformational epitopes that recombinant systems can miss.
- Monoclonal AntibodiesRecombinant and hybridoma clones characterised for Western blot, IHC, immunofluorescence, ELISA and flow cytometry — application data included.
Next step
Tell us the target, we will tell you what is feasible
Send the sequence, assay format and sensitivity you need. You will get a technical assessment — recommended platform, timeline and the risks worth knowing before you commit budget.